Literature DB >> 19830532

Role of mitochondrial-mediated signaling pathways in Alzheimer disease and hypoxia.

Cristina Carvalho1, Sónia C Correia, Renato X Santos, Susana Cardoso, Paula I Moreira, Timothy A Clark, Xiongwei Zhu, Mark A Smith, George Perry.   

Abstract

Development of effective treatments for Alzheimer's disease is complicated by the poor understanding of its pathophysiology. Recent work suggests mitochondria may play a primary role in neurodegeneration, due to alterations in mitochondria turnover and that the brain is specifically susceptible, due to high energy demand. Mitochondria are the major source of cellular energy through oxidative phosphorylation and regulate intracellular calcium levels and survival pathways. Hypoxia has been implicated in several neurodegenerative diseases including Alzheimer's disease. During hypoxic events, mitochondrial complex III produces high levels of reactive oxygen species (ROS). These ROS seem to have a primary role in the regulation of the transcription factor hypoxia inducible factor 1alpha that triggers death effectors. Here we discuss the role of mitochondria in AD putting focus on the activation of hypoxia-mediated mitochondrial pathways, which could eventually lead to cell degeneration and death.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19830532      PMCID: PMC4054815          DOI: 10.1007/s10863-009-9247-1

Source DB:  PubMed          Journal:  J Bioenerg Biomembr        ISSN: 0145-479X            Impact factor:   2.945


  112 in total

Review 1.  Nitric oxide, mitochondria, and cell death.

Authors:  G C Brown; V Borutaite
Journal:  IUBMB Life       Date:  2001 Sep-Nov       Impact factor: 3.885

Review 2.  Proinflammatory and vasoactive effects of Abeta in the cerebrovasculature.

Authors:  K P Townsend; D Obregon; A Quadros; N Patel; Ch Volmar; D Paris; M Mullan
Journal:  Ann N Y Acad Sci       Date:  2002-11       Impact factor: 5.691

Review 3.  Caspase-mediated degeneration in Alzheimer's disease.

Authors:  David H Cribbs; Wayne W Poon; Robert A Rissman; Mathew Blurton-Jones
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

4.  An integrated theory of aging as the result of mitochondrial-DNA mutation in differentiated cells.

Authors:  J Miquel
Journal:  Arch Gerontol Geriatr       Date:  1991 Mar-Jun       Impact factor: 3.250

5.  Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell death.

Authors:  C Stadelmann; T L Deckwerth; A Srinivasan; C Bancher; W Brück; K Jellinger; H Lassmann
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

Review 6.  Cerebral microvascular pathology in aging and Alzheimer's disease.

Authors:  E Farkas; P G Luiten
Journal:  Prog Neurobiol       Date:  2001-08       Impact factor: 11.685

Review 7.  The biochemistry of programmed cell death.

Authors:  G Kroemer; P Petit; N Zamzami; J L Vayssière; B Mignotte
Journal:  FASEB J       Date:  1995-10       Impact factor: 5.191

8.  Enhanced spontaneous transmitter release is the earliest consequence of neocortical hypoxia that can explain the disruption of normal circuit function.

Authors:  I A Fleidervish; C Gebhardt; N Astman; M J Gutnick; U Heinemann
Journal:  J Neurosci       Date:  2001-07-01       Impact factor: 6.167

9.  High altitude memory impairment is due to neuronal apoptosis in hippocampus, cortex and striatum.

Authors:  Panchanan Maiti; Shashi B Singh; Birendranath Mallick; Sangu Muthuraju; Govindasami Ilavazhagan
Journal:  J Chem Neuroanat       Date:  2008-07-15       Impact factor: 3.052

Review 10.  Targeting mitochondria.

Authors:  Adam T Hoye; Jennifer E Davoren; Peter Wipf; Mitchell P Fink; Valerian E Kagan
Journal:  Acc Chem Res       Date:  2008-01       Impact factor: 22.384

View more
  24 in total

Review 1.  Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders.

Authors:  Berislav V Zlokovic
Journal:  Nat Rev Neurosci       Date:  2011-11-03       Impact factor: 34.870

2.  Mitochondrial matters of the brain: amyloid formation and Alzheimer's disease introduction.

Authors:  Peter L Pedersen
Journal:  J Bioenerg Biomembr       Date:  2009-10       Impact factor: 2.945

3.  D-galactose effectiveness in modeling aging and therapeutic antioxidant treatment in mice.

Authors:  Kodeeswaran Parameshwaran; Michael H Irwin; Kosta Steliou; Carl A Pinkert
Journal:  Rejuvenation Res       Date:  2011-01-04       Impact factor: 4.663

4.  Cerebral oxygen extraction fraction (OEF): Comparison of challenge-free gradient echo QSM+qBOLD (QQ) with 15O PET in healthy adults.

Authors:  Junghun Cho; John Lee; Hongyu An; Manu S Goyal; Yi Su; Yi Wang
Journal:  J Cereb Blood Flow Metab       Date:  2020-11-27       Impact factor: 6.200

Review 5.  Cerebral Microvascular Injury: A Potentially Treatable Endophenotype of Traumatic Brain Injury-Induced Neurodegeneration.

Authors:  Danielle K Sandsmark; Asma Bashir; Cheryl L Wellington; Ramon Diaz-Arrastia
Journal:  Neuron       Date:  2019-08-07       Impact factor: 17.173

Review 6.  Cerebrovascular and mitochondrial abnormalities in Alzheimer's disease: a brief overview.

Authors:  Cristina Carvalho; Sónia C Correia; George Perry; Rudy J Castellani; Paula I Moreira
Journal:  J Neural Transm (Vienna)       Date:  2015-01-22       Impact factor: 3.575

7.  CD36 upregulation mediated by intranasal LV-NRF2 treatment mitigates hypoxia-induced progression of Alzheimer's-like pathogenesis.

Authors:  Chun-Yan Wang; Zhan-You Wang; Jing-Wei Xie; Jian-Hui Cai; Tao Wang; Ye Xu; Xu Wang; Li An
Journal:  Antioxid Redox Signal       Date:  2014-05-16       Impact factor: 8.401

8.  Increased susceptibility to amyloid-β toxicity in rat brain microvascular endothelial cells under hyperglycemic conditions.

Authors:  Cristina Carvalho; Paige S Katz; Somhrita Dutta; Prasad V G Katakam; Paula I Moreira; David W Busija
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

9.  Ginkgo biloba extract ameliorates oxidative phosphorylation performance and rescues abeta-induced failure.

Authors:  Virginie Rhein; Maria Giese; Ginette Baysang; Fides Meier; Stefania Rao; Kathrin L Schulz; Matthias Hamburger; Anne Eckert
Journal:  PLoS One       Date:  2010-08-24       Impact factor: 3.240

10.  Amyloid-beta disrupts calcium and redox homeostasis in brain endothelial cells.

Authors:  Ana Catarina R G Fonseca; Paula I Moreira; Catarina R Oliveira; Sandra M Cardoso; Paolo Pinton; Cláudia F Pereira
Journal:  Mol Neurobiol       Date:  2014-05-16       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.